ArticleThe Journal of endocrinology2008

The novel inosine analogue, INO-2002, protects against diabetes development in multiple low-dose streptozotocin and non-obese diabetic mouse models of type I diabetes.

Jon G Mabley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.